Cite
HARVARD Citation
Hassoun, H. et al. (2020). A phase II clinical trial of lenalidomide intensification in patients with serologic/asymptomatic progression of multiple myeloma while on lenalidomide maintenance: a tri-state transplant consortium study. Leukemia & lymphoma. 61 (2), pp. 488-490. [Online].